Chantar, principal investigator at CIC bioGUNE and CIBERehd, has identified a new therapeutic target for cholangiocarcinoma ...

Advances in heart care are moving fast. What once required open-heart surgery can now often be treated with a tiny incision and a few hours of recovery. At the forefront of this shift is King’s ...

Researchers at Tel Aviv University have developed a new approach for using locked nucleic acids (LNAs)—a particularly stable ...

Gene expression governs whether neuroblastoma tumor cells exist in either the adrenergic (differentiated and sensitive to ...

A novel drug-releasing system for bladder cancer that allows for sustained delivery of medicine for several weeks recently received FDA approval after producing superior and longer-lasting response ...